SeaStar Medical Holding Corporation (ICU)
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
$20.41M
Mr. Eric Schlorff
3.00
Denver, CO
Mar 18, 2021
-0.26
$-18.55
0.52
0.68
0.00%
-14.99
0.37
-112.82
0.00
0.52
-434.97%
294.72%
Similar stocks (13)
Immix Biopharma, Inc.
IMMX
Unicycive Therapeutics, Inc.
UNCY
Virios Therapeutics, Inc.
VIRI
CNS Pharmaceuticals, Inc.
CNSP
Allarity Therapeutics, Inc.
ALLR
Palisade Bio, Inc.
PALI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Kiromic BioPharma, Inc.
KRBP
ZyVersa Therapeutics, Inc.
ZVSA
Quoin Pharmaceuticals, Ltd.
QNRX
Revelation Biosciences, Inc.
REVB
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Immix Biopharma, Inc.
IMMX
Unicycive Therapeutics, Inc.
UNCY
Virios Therapeutics, Inc.
VIRI
CNS Pharmaceuticals, Inc.
CNSP
Allarity Therapeutics, Inc.
ALLR
Palisade Bio, Inc.
PALI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Kiromic BioPharma, Inc.
KRBP
ZyVersa Therapeutics, Inc.
ZVSA
Quoin Pharmaceuticals, Ltd.
QNRX
Revelation Biosciences, Inc.
REVB
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%